Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies

Artemisinin‐based combination therapies (ACTs) are currently unaffordable for many of the people who need them most. A major cost component of ACTs is the plant‐derived artemisinin. A fermentation process for a precursor to artemisinin might provide a viable second source to stabilize the artemisini...

Ausführliche Beschreibung